Moreover, immunostaining for the endogenous MMP inhibitor TIMP1, a marker of liver fibrosis, together with zymographic analysis of collagenase activity demonstrated that GS341 treatment promotes the disengagement of collagenase activity from TIMP1, while moving toward the fibrotic scar area (Figure 6B). The gene discussed is TIMP1; the disease is Hepatic fibrosis.